570 results on '"Ikejima, Kenichi"'
Search Results
2. Benefit of an action camera in endoscopy education for medical students under COVID-19
3. Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease
4. Autophagic dysfunction in the liver enhances the expression of insoluble nuclear proteins 14-3-3ζ and importin α4
5. Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment
6. Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma
7. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
8. Hepatic steatosis and skeletal muscle alterations during the COVID‐19 lockdown in a cohort of patients with chronic liver disease in Japan
9. MR Fingerprinting for Contrast Agent–free and Quantitative Characterization of Focal Liver Lesions
10. Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury
11. Cathepsin L-deficiency enhances liver regeneration after partial hepatectomy
12. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease
13. Hepatic steatosis and skeletal muscle alterations during the COVID‐19 lockdown in a cohort of patients with chronic liver disease in Japan.
14. Carbohydrate-deficient transferrin is a suitable drinking marker for patients with metabolic dysfunction-associated fatty liver disease
15. Type I NKT cells are involved in exacerbation of steatohepatitis in aged mice
16. High-fat diet exacerbates lipopolysaccharide-induced liver injury in obese KK-Ay mice
17. Benefit of an action camera in endoscopy education for medical students under COVID-19
18. The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
19. Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma
20. Spleen-derived lipocalin-2 in the portal vein regulates Kupffer cells activation and attenuates the development of liver fibrosis in mice
21. MR Fingerprinting for Liver Tissue Characterization: A Histopathologic Correlation Study
22. Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma
23. Sodium 4-phenylbutyric acid prevents murine acetaminophen hepatotoxicity by minimizing endoplasmic reticulum stress
24. Amino acid glycine suppresses steatohepatitis and tumorigenesis in hepatocyte-specific phosphatase and tensin homolog knockout mice
25. Experimental fibrosis alters matrix-bound vesicles cargo that do not revert after histologic recovery
26. Genetic Manipulation of Liver Sinusoidal Endothelial Cells
27. Role of Leptin in Pathogenesis of NASH
28. A case of aneurysm in the splenorenal collateral treated by BRTO with GERTO in a patient on maintenance dialysis accompanied by alcoholic liver fibrosis
29. Tu1298: TYPE I AND II NATURAL KILLER T CELLS ARE INVOLVED IN THE DEVELOPMENT OF STEATOHEPATITIS IN ELDER MICE
30. Su1552 GLYCINE PREVENTS STEATOHEPATITIS-ASSOCIATED HEPATOCARCINOGENESIS IN HEPATOCYTE-SPECIFIC PTEN KNOCKOUT MICE THROUGH OF LIPID PROFILES
31. L‐carnitine prevents metabolic steatohepatitis in obese diabetic KK‐Ay mice
32. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
33. Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling
34. Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNA
35. Recurrent severe acute hepatitis caused by hypereosinophilic syndrome associated with elevated serum immunoglobulin G4 levels
36. Death Receptor 5 Mediated-Apoptosis Contributes to Cholestatic Liver Disease
37. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis
38. Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
39. Carbohydrate-Deficient Transferrin is a Sensitive Marker of Alcohol Consumption in Fatty Liver Disease
40. A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites
41. Role of mitochondria in liver pathophysiology
42. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury
43. A Genome-Wide Association Study Identifying SVEP1 Variant as a Predictor of Response to Tolvaptan for Cirrhotic Ascites
44. Loss of autophagy promotes murine acetaminophen hepatotoxicity
45. Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
46. Diabetic [KK-A.sup.y] mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen
47. Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease
48. The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation
49. Liver diseases and metabolic syndrome
50. Proceeding of the Ronald G. Thurman Memorial Symposium 2020
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.